Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line

Recent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which could be responsible for recurrence of cancer. Aldehyde dehydrogenase 1 (ALDH1) activity has used as a...

Full description

Saved in:
Bibliographic Details
Published inIranian journal of cancer prevention Vol. 8; no. 5; p. e3446
Main Authors Khorrami, Samaneh, Zavaran Hosseini, Ahmad, Mowla, Seyed Javad, Malekzadeh, Reza
Format Journal Article
LanguageEnglish
Published Iran Shahid Beheshti University of Medical Sciences 01.10.2015
Subjects
Online AccessGet full text
ISSN2008-2398
2008-2401
DOI10.17795/ijcp-3446

Cover

Abstract Recent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which could be responsible for recurrence of cancer. Aldehyde dehydrogenase 1 (ALDH1) activity has used as a functional stem cell biomarker to isolate CSCs in different cancers such as colorectal cancer. The main aim of this research was to determine the utility of ALDH1 activity along with CD44 and EPCAM in identifying stem cell-like cells in human HT-29 colonic adenocarcinoma cell line. In this experimental study, colon CSCs biomarkers including CD44, EPCAM and ALDH1 in colonospheres and parent cells have analyzed by flow cytometry. The expression levels of stemness genes in spheroid and parental cells have investigated using SYBR Green real-time PCR. In addition, in vivo xenografts assay has performed to determine tumorigenic potential of tumor spheroid cells in nude mice. According to results, over 92% of spheroids were CD44+/EpCAM+, while parent cells only have expressed 38% of CD44/EpCAM biomarkers (P < 0.001). Controversially, ALDH activity was about 2-fold higher in the parent cells than spheroid cells (P < 0.05). In comparison with the parental cells, expression levels of ''stemness'' genes, like Sox2, Oct4, Nanog, C-myc, and Klf4 have significantly increased in colonosphere cells (P < 0.05). Further, administration of 2500 spheroids could be sufficient to initiate tumor growth in nude mice, while 1x106 of parental cells has needed to form tumor. For the first time, we have shown that colonospheres with low ALDH1 activity has indicated increased tumorigenic potential and stemness properties. So, it hasn't seemed that ALDH1 could become a useful biomarker to identify CSCs population in HT-29 cell line.
AbstractList BACKGROUNDRecent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which could be responsible for recurrence of cancer. Aldehyde dehydrogenase 1 (ALDH1) activity has used as a functional stem cell biomarker to isolate CSCs in different cancers such as colorectal cancer.OBJECTIVESThe main aim of this research was to determine the utility of ALDH1 activity along with CD44 and EPCAM in identifying stem cell-like cells in human HT-29 colonic adenocarcinoma cell line.MATERIALS AND METHODSIn this experimental study, colon CSCs biomarkers including CD44, EPCAM and ALDH1 in colonospheres and parent cells have analyzed by flow cytometry. The expression levels of stemness genes in spheroid and parental cells have investigated using SYBR Green real-time PCR. In addition, in vivo xenografts assay has performed to determine tumorigenic potential of tumor spheroid cells in nude mice.RESULTSAccording to results, over 92% of spheroids were CD44+/EpCAM+, while parent cells only have expressed 38% of CD44/EpCAM biomarkers (P < 0.001). Controversially, ALDH activity was about 2-fold higher in the parent cells than spheroid cells (P < 0.05). In comparison with the parental cells, expression levels of ''stemness'' genes, like Sox2, Oct4, Nanog, C-myc, and Klf4 have significantly increased in colonosphere cells (P < 0.05). Further, administration of 2500 spheroids could be sufficient to initiate tumor growth in nude mice, while 1x106 of parental cells has needed to form tumor.CONCLUSIONSFor the first time, we have shown that colonospheres with low ALDH1 activity has indicated increased tumorigenic potential and stemness properties. So, it hasn't seemed that ALDH1 could become a useful biomarker to identify CSCs population in HT-29 cell line.
Recent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells termed cancer stem cells (CSCs) which could be responsible for recurrence of cancer. Aldehyde dehydrogenase 1 (ALDH1) activity has used as a functional stem cell biomarker to isolate CSCs in different cancers such as colorectal cancer. The main aim of this research was to determine the utility of ALDH1 activity along with CD44 and EPCAM in identifying stem cell-like cells in human HT-29 colonic adenocarcinoma cell line. In this experimental study, colon CSCs biomarkers including CD44, EPCAM and ALDH1 in colonospheres and parent cells have analyzed by flow cytometry. The expression levels of stemness genes in spheroid and parental cells have investigated using SYBR Green real-time PCR. In addition, in vivo xenografts assay has performed to determine tumorigenic potential of tumor spheroid cells in nude mice. According to results, over 92% of spheroids were CD44+/EpCAM+, while parent cells only have expressed 38% of CD44/EpCAM biomarkers (P < 0.001). Controversially, ALDH activity was about 2-fold higher in the parent cells than spheroid cells (P < 0.05). In comparison with the parental cells, expression levels of ''stemness'' genes, like Sox2, Oct4, Nanog, C-myc, and Klf4 have significantly increased in colonosphere cells (P < 0.05). Further, administration of 2500 spheroids could be sufficient to initiate tumor growth in nude mice, while 1x106 of parental cells has needed to form tumor. For the first time, we have shown that colonospheres with low ALDH1 activity has indicated increased tumorigenic potential and stemness properties. So, it hasn't seemed that ALDH1 could become a useful biomarker to identify CSCs population in HT-29 cell line.
Author Zavaran Hosseini, Ahmad
Khorrami, Samaneh
Mowla, Seyed Javad
Malekzadeh, Reza
AuthorAffiliation 1 Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
2 Department of Molecular Genetics, Faculty of Biological Sciences , Tarbiat Modares University, Tehran, IR Iran
3 Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran
AuthorAffiliation_xml – name: 2 Department of Molecular Genetics, Faculty of Biological Sciences , Tarbiat Modares University, Tehran, IR Iran
– name: 3 Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran
– name: 1 Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
Author_xml – sequence: 1
  givenname: Samaneh
  surname: Khorrami
  fullname: Khorrami, Samaneh
– sequence: 2
  givenname: Ahmad
  surname: Zavaran Hosseini
  fullname: Zavaran Hosseini, Ahmad
– sequence: 3
  givenname: Seyed Javad
  surname: Mowla
  fullname: Mowla, Seyed Javad
– sequence: 4
  givenname: Reza
  surname: Malekzadeh
  fullname: Malekzadeh, Reza
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26634106$$D View this record in MEDLINE/PubMed
BookMark eNptkctOAyEUhonReN_4AIalMRmFgeGyManjpSZNXFjdEsqAolOow7SJby_WatTIhsv5zn_O4d8B6yEGC8ABRieYc1md-mczKwilbA1slwiJoqQIr3-diRRbYD-lZ5QXIVggvAm2SsYIxYhtA_VgO--80b2PAUYHB6OLIRyY3i98_wZ1ghqe-zjV3YvtoA-wjm0Gax1Mvt_1dgpr27apuMg6C9vA4bgo5fINjnywe2DD6TbZ_dW-C-6vLsf1sBjdXt_Ug1FhKKV90VjDGymxLZ2sMMXYUi4cLo10gjtW8coxwSciBysiOW2aSmBqJiQPyCiqyC44-9SdzSdT2xgb-k63atb53Pqbitqr35Hgn9RjXCjKGC8JzQJHK4Euvs5t6tXUJ5PH0MHGeVKYU8kQ4ZXI6OHPWt9Fvn41A8efgOliSp113whGauma-nBNfbiWYfQHNr5f2pH79O1_Ke812pgV
CitedBy_id crossref_primary_10_1016_j_phymed_2021_153484
crossref_primary_10_2174_1574888X13666180810120012
crossref_primary_10_1021_acs_analchem_1c02316
crossref_primary_10_1002_jcp_28132
crossref_primary_10_2174_0113816128291321240329050945
crossref_primary_10_1007_s12032_021_01488_9
crossref_primary_10_1016_j_semcancer_2023_01_001
crossref_primary_10_1016_j_bbrc_2021_12_089
crossref_primary_10_3389_fcell_2023_1231416
crossref_primary_10_1002_jcp_25318
crossref_primary_10_3892_etm_2017_4846
crossref_primary_10_1016_j_prp_2019_03_008
crossref_primary_10_2217_fon_2017_0091
crossref_primary_10_1002_biof_70002
crossref_primary_10_23868_201808016
crossref_primary_10_3390_molecules24244520
crossref_primary_10_3892_or_2016_5120
crossref_primary_10_5812_ijcm_5700
crossref_primary_10_1002_iub_2166
Cites_doi 10.2174/157488808786734006
10.1073/pnas.0805706105
10.1038/nature05384
10.1158/0008-5472.CAN-06-3281
10.3390/cancers30100716
10.1245/s10434-009-0567-5
10.1016/j.stem.2007.08.014
10.1016/j.jim.2009.06.008
10.1038/35102167
10.1136/jcp.2004.016238
10.1073/pnas.0703478104
10.1245/s10434-009-0617-z
10.1371/journal.pone.0010731
10.1158/0008-5472.CAN-08-4418
10.1186/1471-2407-12-42
10.1186/1476-4598-9-212
10.1002/stem.1170
10.1038/nature05372
10.1016/j.canlet.2009.02.033
10.1093/jnci/djj495
10.1158/0008-5472.CAN-04-0328
10.1002/ijc.24061
10.1016/j.stem.2007.10.015
ContentType Journal Article
Copyright Copyright © 2015, Iranian Journal of Cancer Prevention. 2015
Copyright_xml – notice: Copyright © 2015, Iranian Journal of Cancer Prevention. 2015
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.17795/ijcp-3446
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2008-2401
EndPage e3446
ExternalDocumentID PMC4667234
26634106
10_17795_ijcp_3446
Genre Journal Article
GroupedDBID 04C
53G
AAWTL
AAYXX
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BMSDO
CITATION
C~G
DIK
DYU
EBD
EIHBH
HYE
KQ8
M48
OK1
PGMZT
RNS
RPM
NPM
7X8
5PM
ID FETCH-LOGICAL-c444t-dec7d991e2f951411e478f12c9f87f6575f687b895153974dd5814cb323964053
IEDL.DBID M48
ISSN 2008-2398
IngestDate Thu Aug 21 17:47:10 EDT 2025
Thu Jul 10 22:23:23 EDT 2025
Mon Jul 21 06:01:15 EDT 2025
Wed Aug 27 16:27:18 EDT 2025
Thu Apr 24 23:10:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 5
Keywords Colorectal Cancer
ALDH
Biomarker
Cancer Stem Cell
HT-29
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c444t-dec7d991e2f951411e478f12c9f87f6575f687b895153974dd5814cb323964053
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.17795/ijcp-3446
PMID 26634106
PQID 1749603758
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4667234
proquest_miscellaneous_1749603758
pubmed_primary_26634106
crossref_primary_10_17795_ijcp_3446
crossref_citationtrail_10_17795_ijcp_3446
PublicationCentury 2000
PublicationDate 2015-10-01
PublicationDateYYYYMMDD 2015-10-01
PublicationDate_xml – month: 10
  year: 2015
  text: 2015-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Iran
PublicationPlace_xml – name: Iran
PublicationTitle Iranian journal of cancer prevention
PublicationTitleAlternate Iran J Cancer Prev
PublicationYear 2015
Publisher Shahid Beheshti University of Medical Sciences
Publisher_xml – name: Shahid Beheshti University of Medical Sciences
References key-A3446REF25-25
key-A3446REF12-12
key-A3446REF14-14
key-A3446REF16-16
Moreb JS (key-A3446REF15-15) 2008; 3
key-A3446REF9-9
key-A3446REF8-8
key-A3446REF7-7
key-A3446REF6-6
key-A3446REF21-21
Yu C (key-A3446REF24-24) 2011; 25
key-A3446REF5-5
key-A3446REF23-23
key-A3446REF4-4
key-A3446REF3-3
key-A3446REF2-2
key-A3446REF1-1
Willson JK (key-A3446REF18-18) 1987; 47
key-A3446REF10-10
key-A3446REF11-11
key-A3446REF13-13
key-A3446REF17-17
key-A3446REF19-19
key-A3446REF20-20
key-A3446REF22-22
18938743 - Cell Stem Cell. 2007 Nov;1(5):485-7
17122772 - Nature. 2007 Jan 4;445(7123):106-10
17548814 - Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63
18371393 - Cell Stem Cell. 2007 Nov;1(5):555-67
22280212 - BMC Cancer. 2012 Jan 26;12:42
17332349 - Cancer Res. 2007 Mar 1;67(5):2187-96
3567899 - Cancer Res. 1987 May 15;47(10):2704-13
19657699 - Ann Surg Oncol. 2009 Dec;16(12 ):3488-98
19336570 - Cancer Res. 2009 Apr 15;69(8):3382-9
15256451 - Cancer Res. 2004 Jul 15;64(14):4817-25
18765800 - Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13427-32
21282737 - In Vivo. 2011 Jan-Feb;25(1):69-76
20691072 - Mol Cancer. 2010 Aug 06;9:212
20505780 - PLoS One. 2010 May 20;5(5):e10731
11689955 - Nature. 2001 Nov 1;414(6859):105-11
19324493 - Cancer Lett. 2009 Aug 18;281(1):92-9
21643534 - Cancers (Basel). 2011 Feb 21;3(1):716-29
19554373 - Ann Surg Oncol. 2009 Sep;16(9):2638-44
22782858 - Stem Cells. 2012 Sep;30(9):1831-41
19567251 - J Immunol Methods. 2009 Aug 15;347(1-2):70-8
17122771 - Nature. 2007 Jan 4;445(7123):111-5
17179479 - J Natl Cancer Inst. 2006 Dec 20;98 (24):1777-85
19072981 - Int J Cancer. 2009 Mar 15;124(6):1312-21
15509676 - J Clin Pathol. 2004 Nov;57(11):1160-4
19075754 - Curr Stem Cell Res Ther. 2008 Dec;3(4):237-46
References_xml – volume: 3
  start-page: 237
  issue: 4
  year: 2008
  ident: key-A3446REF15-15
  publication-title: Curr Stem Cell Res Ther.
  doi: 10.2174/157488808786734006
– ident: key-A3446REF7-7
  doi: 10.1073/pnas.0805706105
– ident: key-A3446REF2-2
  doi: 10.1038/nature05384
– ident: key-A3446REF13-13
  doi: 10.1158/0008-5472.CAN-06-3281
– ident: key-A3446REF8-8
  doi: 10.3390/cancers30100716
– ident: key-A3446REF10-10
  doi: 10.1245/s10434-009-0567-5
– ident: key-A3446REF12-12
  doi: 10.1016/j.stem.2007.08.014
– ident: key-A3446REF20-20
  doi: 10.1016/j.jim.2009.06.008
– ident: key-A3446REF1-1
  doi: 10.1038/35102167
– ident: key-A3446REF6-6
  doi: 10.1136/jcp.2004.016238
– ident: key-A3446REF4-4
  doi: 10.1073/pnas.0703478104
– volume: 47
  start-page: 2704
  issue: 10
  year: 1987
  ident: key-A3446REF18-18
  publication-title: Cancer Res.
– ident: key-A3446REF9-9
  doi: 10.1245/s10434-009-0617-z
– ident: key-A3446REF25-25
  doi: 10.1371/journal.pone.0010731
– ident: key-A3446REF16-16
  doi: 10.1158/0008-5472.CAN-08-4418
– ident: key-A3446REF11-11
  doi: 10.1186/1471-2407-12-42
– ident: key-A3446REF19-19
  doi: 10.1186/1476-4598-9-212
– ident: key-A3446REF23-23
  doi: 10.1002/stem.1170
– ident: key-A3446REF3-3
  doi: 10.1038/nature05372
– ident: key-A3446REF21-21
  doi: 10.1016/j.canlet.2009.02.033
– ident: key-A3446REF22-22
  doi: 10.1093/jnci/djj495
– ident: key-A3446REF17-17
  doi: 10.1158/0008-5472.CAN-04-0328
– volume: 25
  start-page: 69
  issue: 1
  year: 2011
  ident: key-A3446REF24-24
  publication-title: In Vivo.
– ident: key-A3446REF5-5
  doi: 10.1002/ijc.24061
– ident: key-A3446REF14-14
  doi: 10.1016/j.stem.2007.10.015
– reference: 15509676 - J Clin Pathol. 2004 Nov;57(11):1160-4
– reference: 20691072 - Mol Cancer. 2010 Aug 06;9:212
– reference: 19657699 - Ann Surg Oncol. 2009 Dec;16(12 ):3488-98
– reference: 17122771 - Nature. 2007 Jan 4;445(7123):111-5
– reference: 21643534 - Cancers (Basel). 2011 Feb 21;3(1):716-29
– reference: 17179479 - J Natl Cancer Inst. 2006 Dec 20;98 (24):1777-85
– reference: 18371393 - Cell Stem Cell. 2007 Nov;1(5):555-67
– reference: 15256451 - Cancer Res. 2004 Jul 15;64(14):4817-25
– reference: 22280212 - BMC Cancer. 2012 Jan 26;12:42
– reference: 17122772 - Nature. 2007 Jan 4;445(7123):106-10
– reference: 17548814 - Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63
– reference: 19567251 - J Immunol Methods. 2009 Aug 15;347(1-2):70-8
– reference: 17332349 - Cancer Res. 2007 Mar 1;67(5):2187-96
– reference: 11689955 - Nature. 2001 Nov 1;414(6859):105-11
– reference: 19336570 - Cancer Res. 2009 Apr 15;69(8):3382-9
– reference: 19324493 - Cancer Lett. 2009 Aug 18;281(1):92-9
– reference: 19554373 - Ann Surg Oncol. 2009 Sep;16(9):2638-44
– reference: 19075754 - Curr Stem Cell Res Ther. 2008 Dec;3(4):237-46
– reference: 22782858 - Stem Cells. 2012 Sep;30(9):1831-41
– reference: 18938743 - Cell Stem Cell. 2007 Nov;1(5):485-7
– reference: 18765800 - Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13427-32
– reference: 20505780 - PLoS One. 2010 May 20;5(5):e10731
– reference: 19072981 - Int J Cancer. 2009 Mar 15;124(6):1312-21
– reference: 21282737 - In Vivo. 2011 Jan-Feb;25(1):69-76
– reference: 3567899 - Cancer Res. 1987 May 15;47(10):2704-13
SSID ssj0000331801
Score 2.137591
Snippet Recent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing, multi-potent cells...
BACKGROUNDRecent evidence has suggested that epithelial cancers including colorectal cancer (CRC) have driven by a small population of self-renewing,...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e3446
Title Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line
URI https://www.ncbi.nlm.nih.gov/pubmed/26634106
https://www.proquest.com/docview/1749603758
https://pubmed.ncbi.nlm.nih.gov/PMC4667234
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVCAB
  databaseName: Nutrition and Food Sciences Database
  customDbUrl:
  eissn: 2008-2401
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000331801
  issn: 2008-2398
  databaseCode: DYU
  dateStart: 20090101
  isFulltext: true
  titleUrlDefault: https://www.cabidigitallibrary.org/product/zd
  providerName: CAB International
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2008-2401
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000331801
  issn: 2008-2398
  databaseCode: KQ8
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2008-2401
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000331801
  issn: 2008-2398
  databaseCode: DIK
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2008-2401
  dateEnd: 20161231
  omitProxy: true
  ssIdentifier: ssj0000331801
  issn: 2008-2398
  databaseCode: RPM
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2008-2401
  dateEnd: 20160630
  omitProxy: true
  ssIdentifier: ssj0000331801
  issn: 2008-2398
  databaseCode: M48
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV07T8MwELZ4SIgF8aa8ZAQLgyGJ7dgZECoFVCHKAkVskeOHKCoptAXBv-ecpBUFBpYM8dmK7s6-78tZdwgdaG6UCAwnKuGGMGozoqhxxLgw0cYmimeeKLZu4mabXT3whyk06t9ZKXDwJ7Xz_aTa_e7Rx-vnKWz4E7_hhUj4cedJvxAKxGYazUJEirx3tyqYX5zIFDy36IRcZPt9ybuqUunk9MnY9Atw_rw3-S0QXS6ihQpB4npp8iU0ZfNlNNeqcuQrKL0Hp3LVrzjcc7h-fd7EdV22icBqgBU-6_Se_b2cPu7kuAHnHzy9-fv4dmifccN2uwNyDuu8W4ObdyRKincYmKtdRe3Li7tGk1RtFIhmjA2JsVoYgIE2cgCnWBhaJqQLI504KZxPvLhYikzCIAd0wozhMmQ6o6CnGPAcXUMzeS-3GwgnmkmjpDWOOsaDIAupkYFUzilrE85q6HCkwFRXNcZ9q4tu6rmGV3bqlZ16ZdfQ_lj2pays8afU3sgOKTi-z2ao3PbeBiDIgH1R4Ds1tF7aZbwOoA6IzgHMFhMWGwv4otqTI3nnsSiuzeJYRJRt_uvrttA8ACheXu7bRjPD_pvdAZAyzHYLD_wCFZvmBQ
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Verification+of+ALDH+Activity+as+a+Biomarker+in+Colon+Cancer+Stem+Cells-Derived+HT-29+Cell+Line&rft.jtitle=Iranian+journal+of+cancer+prevention&rft.au=Khorrami%2C+Samaneh&rft.au=Zavaran+Hosseini%2C+Ahmad&rft.au=Mowla%2C+Seyed+Javad&rft.au=Malekzadeh%2C+Reza&rft.date=2015-10-01&rft.issn=2008-2398&rft.eissn=2008-2401&rft.volume=8&rft.issue=5&rft_id=info:doi/10.17795%2Fijcp-3446&rft.externalDBID=n%2Fa&rft.externalDocID=10_17795_ijcp_3446
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2008-2398&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2008-2398&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2008-2398&client=summon